You have 6 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

225Ac-DOTATATE

Showing 26 - 50 of 455
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Long-term Evaluation

Recruiting
  • Atherosclerosis
  • +3 more
  • PET imaging
  • +2 more
  • Cambridge, United Kingdom
    University of Cambridge
Mar 18, 2022

Metastatic Castration-resistant Prostate Cancer Trial (225Ac-PSMA)

Unknown status
  • Metastatic Castration-resistant Prostate Cancer
  • (no location specified)
Jan 8, 2020

Digestive System Neuroendocrine Tumor G1, Digestive System Neuroendocrine Tumor G2, Metastatic Digestive System Neuroendocrine

Not yet recruiting
  • Digestive System Neuroendocrine Tumor G1
  • +5 more
  • Tumor Debulking
  • +5 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Aug 23, 2023

AminoMedixTM for Kidney Protection During Radionuclide Therapy

Completed
  • Radiation Nephropathy
    • (no location specified)
    Mar 22, 2023

    Metastatic Neuroendocrine Tumor Trial (Biospecimen Collection, Computed Tomography, Lutetium Lu 177 Dotatate)

    Not yet recruiting
    • Metastatic Neuroendocrine Tumor
    • Biospecimen Collection
    • +4 more
    • (no location specified)
    Feb 10, 2023

    Hyperparathyroidism, Hypercalcemia, Parathyroid Tumor Trial run by the NIDDK (68Ga-Dotatate, 18F-DOPA)

    Completed
    Has Results
    • Hyperparathyroidism
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    May 12, 2022

    Neuroendocrine Tumor Trial in United States (Lutetium Lu 177 Dotatate, Peposertib)

    Recruiting
    • Neuroendocrine Neoplasm
    • Biospecimen Collection
    • +4 more
    • Duarte, California
    • +3 more
    Jan 12, 2023

    Hepatocellular Carcinoma Trial in Birmingham ([68Ga]DOTATATE-PET/MRI)

    Completed
    Has Results
    • Hepatocellular Carcinoma
    • Birmingham, Alabama
      University of Alabama at Birmingham Medical Center
    Dec 16, 2022

    Diabetes, Type 2, Vascular Inflammation Trial in Amsterdam (Atorvastatin 40 Mg Oral Tablet)

    Completed
    • Diabetes Mellitus, Type 2
    • Vascular Inflammation
    • Atorvastatin 40 Mg Oral Tablet
    • Amsterdam, Noord-Holland, Netherlands
      Amsterdam UMC, location AMC
    Feb 7, 2023

    Patients Re-treated With Lutetium-177 DOTATATE (Lutathera®)

    Completed
    • Neuroendocrine Tumor
    • Lutetium-177 DOTATATE
    • Houston, Texas
      Excel Diagnostics & Nuclear Oncology Center
    Apr 16, 2023

    Macrophage PET/CT Imaging Using 64Cu-DOTATATE for Diagnosis of

    Recruiting
    • Cardiac Sarcoidosis
    • 64Cu-DOTATATE PET/CT scan
    • Copenhagen, Denmark
      Rigshospitalet
    Nov 14, 2023

    Neuroblastoma Trial in Lille, Lyon, Toulouse (PRRT with 177Lu-DOTATATE)

    Not yet recruiting
    • Neuroblastoma
    • PRRT with 177Lu-DOTATATE
    • Lille, France
    • +2 more
    Nov 8, 2022

    Meningioma Trial in Houston (Computed Tomography, Gallium Ga 68-DOTATATE, Positron Emission Tomography)

    Recruiting
    • Meningioma
    • Computed Tomography
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 28, 2022

    Breast Cancer Stage IV Trial in Irvine (Gallium-68)

    Recruiting
    • Breast Cancer Stage IV
    • Irvine, California
      Hoag Memorial Hospital Presbyterian
    May 26, 2023

    Neuroendocrine Tumors, Hyperthyroidism, Thyroid Cancer Trial in London (Nuclear Medicine whole-body, SPECT/CT imaging., PET/CT

    Recruiting
    • Neuroendocrine Tumors
    • +3 more
    • Nuclear Medicine whole-body
    • +4 more
    • London, United Kingdom
      Guy's and St Thomas Hospitals Foundation Trust
    Jan 5, 2022

    Metastatic Digestive System Neuroendocrine Tumor, Metastatic Neuroendocrine Tumor Trial in United States (Lutetium Lu 177

    Recruiting
    • Metastatic Digestive System Neuroendocrine Neoplasm
    • Metastatic Neuroendocrine Tumor
    • Phoenix, Arizona
    • +10 more
    Aug 23, 2022

    Metastatic Midgut Neuroendocrine Tumor, Unresectable Midgut Neuroendocrine Tumor Trial (procedure, drug, other)

    Not yet recruiting
    • Metastatic Midgut Neuroendocrine Tumor
    • Unresectable Midgut Neuroendocrine Tumor
    • Biospecimen Collection
    • +5 more
    • (no location specified)
    Mar 16, 2023

    Coronary Arteriosclerosis Trial in Paris (injection of 68Ga-DOTATATE)

    Terminated
    • Coronary Arteriosclerosis
    • injection of 68Ga-DOTATATE
    • Paris, France
      service de médecine nucléaire-Hôpital Bichat
    Jun 29, 2022

    GEP-NET, Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Copenhagen (18F-FDG, 64Cu-Dotatate)

    Enrolling by invitation
    • GEP-NET
    • +3 more
    • Copenhagen, Denmark
      Rigshospitalet
    Jan 24, 2023

    Advanced Lung Carcinoid Tumor, Functioning Lung Carcinoid Tumor, Locally Advanced Lung Neuroendocrine Tumor Trial in Boston,

    Recruiting
    • Advanced Lung Carcinoid Tumor
    • +11 more
    • Boston, Massachusetts
    • +1 more
    Jul 19, 2022

    Ganglioneuroblastoma, Ganglioneuroma, Metastatic Neuroblastoma Trial in Rochester (Computed Tomography, Gallium Ga 68-DOTATATE,

    Recruiting
    • Ganglioneuroblastoma
    • +2 more
    • Computed Tomography
    • +2 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 30, 2023

    Atheroscleroses, Coronary Trial in Amsterdam (68Ga-Dotatate PET/CT)

    Recruiting
    • Atheroscleroses, Coronary
    • 68Ga-Dotatate PET/CT
    • Amsterdam, Netherlands
      Academic Medical Center
    Sep 8, 2022

    Metastatic Pancreatic Neuroendocrine Tumor, Pancreatic Tumor, Stage III Pancreatic Neuroendocrine Tumor AJCC v8 Trial

    Not yet recruiting
    • Metastatic Pancreatic Neuroendocrine Tumor
    • +4 more
    • Biospecimen Collection
    • +5 more
    • (no location specified)
    Jan 14, 2023

    Neuroendocrine Tumors Trial in Lexington (Telotristat (Low-Dose), Telotristat (High-Dose))

    Recruiting
    • Neuroendocrine Tumors
    • Telotristat (Low-Dose)
    • Telotristat (High-Dose)
    • Lexington, Kentucky
      Markey Cancer Center
    Nov 10, 2022

    68-Ga DOTATATE PET/MRI in Diagnosis and Management of

    Recruiting
    • CNS Tumors
    • +6 more
    • Ga68-DOTATATE-PET/MRI
    • New York, New York
      Weill Cornell Medicine
    Sep 20, 2022